U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags

AgileThought

15/05/2023 08:02

May 15 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including CTI Biopharma, Park National and Playags, on
Monday. 
    
    HIGHLIGHTS
                 * CTI Biopharma Corp  CTIC.O : TD Cowen cuts to market perform from outperform
 
                 * Park National Corp  PRK.A : Piper Sandler cuts to underweight from neutral 
 
                 * Playags Inc  AGS.N : Jefferies raises to buy from hold 
 
 
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order. 
    
                 * 8X8 Inc  EGHT.O : Baird cuts target price to $4 from $5 
 
                 * Agilethought Inc  AGIL.O : Alliance Global Partners cuts target price to $5 from $8 
 
                 * Airsculpt Technologies Inc  AIRS.O : SVB Securities raises target price to $8.75 from
 $6.5 
 
                 * An2 Therapeutics Inc  ANTX.O : SVB Securities cuts target price to $23 from $25 
 
                 * Berry Corporation (Bry)  BRY.O : Jefferies cuts target price to $9 from $11 
 
                 * Crescent Energy Co  CRGY.N : Truist Securities cuts target price to $20 from $21 
 
                 * CTI Biopharma Corp  CTIC.O : TD Cowen cuts to market perform from outperform
 
                 * CTI Biopharma Corp  CTIC.O : TD Cowen raises target price to $9.10 from $8 
 
                 * Cue Health Inc  HLTH.O : BTIG cuts target price to $3 from $5 
 
                 * Dariohealth Corp  DRIO.O : Alliance Global Partners cuts target price to $6 from $7.5 
 
                 * Darling Ingredients Inc  DAR.N : Jefferies cuts target price to $85 from $95 
 
                 * Elanco Animal Health Inc  ELAN.N : Piper Sandler cuts target price to $9 from $12 
 
                 * Enviva Inc  EVA.N : RBC cuts target price to $10 from $32 
 
                 * EOG Resources Inc  EOG.N : Jefferies cuts target price to $138 from $147 
 
                 * Exact Sciences Corp  EXAS.O : BTIG raises target price to $95 from $90 
 
                 * Exact Sciences Corp  EXAS.O : Canaccord Genuity raises target price to $92 from $75 
 
                 * Exact Sciences Corp  EXAS.O : Piper Sandler raises target price to $80 from $70 
 
                 * Exxon Mobil  XOM.N : Jefferies cuts target price to $140 from $148 
 
                 * Fluence Energy Inc  FLNC.O : Goldman Sachs raises target price to $32 from $29 
 
                 * Gain Therapeutics Inc  GANX.O : Chardan Capital Markets raises target price to $6 from
 $5.75 
 
                 * Guardant Health Inc  GH.O : Piper Sandler cuts target price to $30 from $35 
 
                 * Houlihan Lokey Inc  HLI.N : JP Morgan cuts target price to $90 from $94 
 
                 * Immunitybio Inc  IBRX.O : Jefferies cuts target price to $5 from $8 
 
                 * Invitae Corp  NVTA.N : Piper Sandler cuts target price to $1.5 from $1.75 
 
                 * JP Morgan  JPM.N : Jefferies cuts target price to $149 from $152 
 
                 * Landos Biopharma Inc  LABP.O : SVB Securities cuts target price to $1 from $2 
 
                 * Marathon Oil Corp  MRO.N : Jefferies cuts target price to $25 from $29 
 
                 * Mid Penn Bancorp Inc  MPB.O : Stephens cuts target price to $26 from $32 
 
                 * Neogenomics Inc  NEO.O : Piper Sandler raises target price to $23 from $20 
 
                 * Northwest Bancshares Inc  NWBI.O : Stephens cuts target price to $12 from $13.5 
 
                 * Occidental Petroleum Corp  OXY.N : Gerdes Energy Research cuts target price by $5 to $74 
 
                 * Oncocyte Corp  OCX.O : Piper Sandler cuts target price to $0.3 from $0.5 
 
                 * Oncocyte Corp  OCX.O : Stephens cuts target price to $0.20 from $0.40 
 
                 * Orchestra Biomed Holdings Inc  OBIO.O : Piper Sandler raises target price to $20 from $15
 
                 * Park National Corp  PRK.A : Piper Sandler cuts target price to $103 from $115 
 
                 * Park National Corp  PRK.A : Piper Sandler cuts to underweight from neutral 
 
                 * Paysign Inc  PAYS.O : D.A. Davidson cuts target price to $4 from $4.50 
 
                 * Playags Inc  AGS.N : Jefferies raises to buy from hold 
 
                 * Playags Inc  AGS.N : Jefferies raises target price to $10 from $7 
 
                 * Provident Bancorp Inc (Maryland)  PVBC.O : Stephens cuts target price to $9 from $9.5 
 
                 * Quanterix Corp  QTRX.O : Canaccord Genuity raises target price to $19 from $13 
 
                 * Sarepta Therapeutics Inc  SRPT.O : Credit Suisse raises target price to $151 from $138 
 
                 * Sarepta Therapeutics Inc  SRPT.O : SVB Securities raises target price to $175 from $160 
 
                 * Spectrum Brands Holdings Inc  SPB.N : Canaccord Genuity raises target to $87 from $82 
 
                 * Spectrum Pharmaceuticals Inc  SPPI.O : Jefferies cuts to hold from buy
 
                 * Spectrum Pharmaceuticals Inc  SPPI.O : Jefferies cuts target price to $1.50 from $3.50 
 
                 * Synlogic Inc  SYBX.O : SVB Securities cuts target price to $4 from $8 
 
                 * Telesis Bio Inc  TBIO.O : Jefferies cuts target price to $5 from $5.50 
 
                 * Transdigm Group Inc  TDG.N : JP Morgan raises target price to $860 from $780 
 
                 * Twilio Inc  TWLO.N : Baird cuts target price to $56 from $80 
 
                 * Washington Trust Bancorp Inc  WASH.O : Piper Sandler cuts target price to $26 from $27 
 
                 * Washington Trust Bancorp Inc  WASH.O : Piper Sandler raises to neutral from underweight 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))